Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v32-EN Version v14-EN
Language English English
Date Updated 2019-07-30 2019-03-05
Drug Identification Number 01934317 01934317
Brand name ISOPTIN SR ISOPTIN SR
Common or Proper name ISOPTIN SR ISOPTIN SR
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE
Strength(s) 180MG 180MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100BT 100BT
ATC code C08DA C08DA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-03-04
Actual start date 2019-07-02
Estimated end date 2019-07-26 2019-05-01
Actual end date 2019-07-29
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments